Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma

International Journal of Pharmaceutics

Volumn 423, Issue 1, 2012, Pages 55-62

  Huynh, Ngoc Trinh ^a,b   Passirani, Catherine ^a,b   Allard Vannier, Emilie ^a,b   Lemaire, Laurent ^a,b   Roux, Jerome ^c   Garcion, Emmanuel ^a,b   Vessieres, Anne ^d   Benoit, Jean Pierre ^a,b  

^a LUNAM Universite   (France)

^b INSERM   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d PSL RESEARCH UNIVERSITY   (France)

Author keywords

Brain tumour; Convection enhanced delivery (CED); DSPE mPEG2000; Intra carotid injection; PEGylated nanoparticles

Indexed keywords

ANTINEOPLASTIC AGENT; FERROCIPHENOL; LIPID; NANOCAPSULE; NANOCOATING; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EXPERIMENTAL MODEL; FEMALE; FLUORESCENCE; GLIOSARCOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSMOLARITY; PH; PRIORITY JOURNAL; RAT; SURVIVAL TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN; BRAIN NEOPLASMS; DRUG CARRIERS; FEMALE; FERROUS COMPOUNDS; FLUORESCENT DYES; GLIOSARCOMA; HYDROGEN-ION CONCENTRATION; INFUSIONS, PARENTERAL; INJECTIONS, INTRA-ARTERIAL; KAPLAN-MEIER ESTIMATE; LIPIDS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NANOCAPSULES; OSMOLAR CONCENTRATION; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; PLANT LECTINS; POLYETHYLENE GLYCOLS; RATS; RATS, INBRED F344; SOYBEAN PROTEINS; STATIC ELECTRICITY; STEARIC ACIDS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84855821149     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.04.037     Document Type: Conference Paper

References (46)

1. M.I. Alam, S. Beg, A. Samad, S. Baboota, K. Kohli, J. Ali, A. Ahuja, and M. Akbar Strategy for effective brain drug delivery Eur. J. Pharm. Sci. 40 2010 385 403
2. E. Allard, F. Hindre, C. Passirani, L. Lemaire, N. Lepareur, N. Noiret, P. Menei, and J.P. Benoit 188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas Eur. J. Nucl. Med. Mol. Imaging 35 2008 1838 1846
3. E. Allard, N.T. Huynh, A. Vessieres, P. Pigeon, G. Jaouen, J.P. Benoit, and C. Passirani Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model Int. J. Pharm. 379 2009 317 323
4. E. Allard, D. Jarnet, A. Vessieres, S. Vinchon-Petit, G. Jaouen, J.P. Benoit, and C. Passirani Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft Pharm. Res. 27 2010 56 64
5. E. Allard, C. Passirani, and J.P. Benoit Convection-enhanced delivery of nanocarriers for the treatment of brain tumors Biomaterials 30 2009 2302 2318
6. E. Allard, C. Passirani, E. Garcion, P. Pigeon, A. Vessieres, G. Jaouen, and J.P. Benoit Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas J. Control Release 130 2008 146 153
7. A.W. Anderson, J. Xie, J. Pizzonia, R.A. Bronen, D.D. Spencer, and J.C. Gore Effects of cell volume fraction changes on apparent diffusion in human cells Mag. Reson. Imaging 18 2000 689 695 (Pubitemid 30626358)
8. A. Beduneau, F. Hindre, A. Clavreul, J.C. Leroux, P. Saulnier, and J.P. Benoit Brain targeting using novel lipid nanovectors J. Control Release 126 2008 44 49 (Pubitemid 351175685)
9. R.H. Bobo, D.W. Laske, A. Akbasak, P.F. Morrison, R.L. Dedrick, and E.H. Oldfield Convection-enhanced delivery of macromolecules in the brain Proc. Natl. Acad. Sci. U.S.A. 91 1994 2076 2080 (Pubitemid 24092045)
10. B. Chertok, A.E. David, and V.C. Yang Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration Biomaterials 31 2010 6317 6324
11. C. Demougeot, P. Garnier, C. Mossiat, N. Bertrand, M. Giroud, A. Beley, and C. Marie N-acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury J. Neurochem. 77 2001 408 415 (Pubitemid 32298735)
12. E.G Figueiredo, J.W. Faria, and M.J. Teixeira Treatment of recurrent glioblastoma with intra-arterial BCNU [1,3-bis (2-chloroethyl)-1-nitrosourea] Arq. Neuropsiquiatr. 68 2010 778 782
13. D. Fortin, A. Desjardins, A. Benko, T. Niyonsega, and M. Boudrias Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience Cancer 103 2005 2606 2615 (Pubitemid 40800541)
14. T. Fujiwara, Y. Matsumoto, Y. Honma, H. Kuyama, S. Nagao, and M. Ohkawa A comparison of intraarterial carboplatin and ACNU for the treatment of gliomas Surg. Neurol. 44 1995 145 150
15. E. Garcion, A. Lamprecht, B. Heurtault, A. Paillard, A. Aubert-Pouessel, B. Denizot, P. Menei, and J.P. Benoit A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats Mol. Cancer Ther. 5 2006 1710 1722 (Pubitemid 44323239)
16. S.A. Grossman, and J.F. Batara Current management of glioblastoma multiforme Semin. Oncol. 31 2004 635 644 (Pubitemid 39389014)
17. W.A. Hall Transferrin receptor on glioblastoma multiforme J. Neurosurg. 74 1991 313 314
18. B. Heurtault, P. Saulnier, B. Pech, J.E. Proust, and J.P. Benoit A novel phase inversion-based process for the preparation of lipid nanocarriers Pharm. Res. 19 2002 875 880 (Pubitemid 34692585)
19. E. Hillard, A. Vessieres, L. Thouin, G. Jaouen, and C. Amatore Ferrocene-mediated proton-coupled electron transfer in a series of ferrocifen-type breast-cancer drug candidates Angew. Chem. - Int. Ed. 45 2005 285 290 (Pubitemid 43017528)
20. R.L. Hong, C.J. Huang, Y.L. Tseng, V.F. Pang, S.T. Chen, J.J. Liu, and F.H. Chang Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial? Clin. Cancer Res. 5 1999 3645 3652
21. N.T. Huynh, C. Passirani, P. Saulnier, and J.P. Benoit Lipid nanocapsules: a new platform for nanomedicine Int. J. Pharm. 379 2009 201 209
22. N.T. Huynh, E. Roger, N. Lautram, J.P. Benoit, and C. Passirani The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting Nanomedicine (Lond) 5 2010 1415 1433
23. G. Jaouen, S. Top, A. Vessieres, and R. Alberto New paradigms for synthetic pathways inspired by bioorganometallic chemistry J. Organomet. Chem. 600 2000 23 36
24. G. Jaouen, S. Top, A. Vessires, G. Leclercq, J. Quivy, L. Jin, and A. Croisy The first organometallic antioestrogens and their antiproliferative effects C. R.Acad. Sci. - Ser. IIc: Chem. 3 2000 89 93
25. S. Joshi, P.M. Meyers, and E. Ornstein Intracarotid delivery of drugs: the potential and the pitfalls Anesthesiology 109 2008 543 564
26. L. Lemaire, F. Franconi, J.J. Lejeune, P. Jallet, and P. Richomme Improving the detection of low concentration metabolites in magnetic resonance spectroscopy by digital filtering Med. Biol. Eng. Comput. 37 1999 244 246 (Pubitemid 29131296)
27. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, A. Jouvet, B.W. Scheithauer, and P. Kleihues The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol. 114 2007 97 109 (Pubitemid 47103521)
28. E.H. Luh, S.R. Shackford, M.A. Shatos, and J.A. Pietropaoli The effects of hyperosmolarity on the viability and function of endothelial cells J. Surg. Res. 60 1996 122 128 (Pubitemid 26044307)
29. J.R. Moffett, B. Ross, P. Arun, C.N. Madhavarao, and A.M.A. Namboodiri N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology Prog. Neurobiol. 81 2007 89 131 (Pubitemid 46282272)
30. M. Morille, T. Montier, P. Legras, N. Carmoy, P. Brodin, B. Pitard, J.P. Benoit, and C. Passirani Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting Biomaterials 31 2010 321 329
31. M. Morille, C. Passirani, E. Letrou-Bonneval, J.P. Benoit, and B. Pitard Galactosylated DNA lipid nanocapsules for efficient hepatocyte targeting Int. J. Pharm. 379 2009 293 300
32. H.B. Newton Intra-arterial chemotherapy B.N. Herbert, M.D. Faan, Handbook of Brain Tumor Chemotherapy first ed. 2006 Academic Press San Diego 247 261
33. H.B. Newton, M.A. Slivka, C. Volpi, E.C. Bourekas, G.A. Christoforidis, M.A. Baujan, W. Slone, and D.W. Chakeres Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors J. Neurooncol. 61 2003 35 44 (Pubitemid 36187642)
34. W.M. Pardridge The blood-brain barrier: bottleneck in brain drug development NeuroRx 2 2005 3 14 (Pubitemid 40128022)
35. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global Cancer Statistics, 2002 CA: Cancer J. Clin. 55 2005 74 108 (Pubitemid 40372904)
36. L. Petit, F. Masson, V. Cottenceau, and F. Sztark Hypernatrémie contrôlée Ann. Fr. Anesth. Reanim. 25 2006 828 837
37. S.I. Rapoport Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications Cell. Mol. Neurobiol. 20 2000 217 230 (Pubitemid 30091457)
38. B.C. Schem, and B.K. Krossnes Enhancement of ACNU treatment of the BT4an rat glioma by local brain hyperthermia and intra-arterial drug administration Eur. J. Cancer 31 1995 1869 1874
39. N. Schuff, D.J. Meyerhoff, S. Mueller, L. Chao, D.T. Sacrey, K. Laxer, and M.W. Weiner N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease Adv. Exp. Med. Biol. 576 2006 241 262 discussion 361-243
40. M.B. Segal The choroid plexuses and the barriers between the blood and the cerebrospinal fluid Cell. Mol. Neurobiol. 20 2000 183 196 (Pubitemid 30091455)
41. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J. Taphoorn, K. Belanger, A.A. Brandes, C. Marosi, and U. Bogdahn Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N. Engl. J. Med. 352 2005 987 996 (Pubitemid 40349501)
42. S. Top, A. Vessieres, G. Leclercq, J. Quivy, J. Tang, J. Vaissermann, M. Huche, and G. Jaouen Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines Chemistry 9 2003 5223 5236
43. J.G. Verbalis Brain volume regulation in response to changes in osmolality Neuroscience 168 2010 862 870
44. A. Vessieres, S. Top, P. Pigeon, E. Hillard, L. Boubeker, D. Spera, and G. Jaouen Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro J. Med. Chem. 48 2005 3937 3940 (Pubitemid 40800602)
45. S. Vinchon-Petit, D. Jarnet, A. Paillard, J.P. Benoit, E. Garcion, and P. Menei In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy J. Neurooncol. 97 2010 195 205
46. A. Vonarbourg, P. Saulnier, C. Passirani, and J.P. Benoit Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface Electrophoresis 26 2005 2066 2075 (Pubitemid 40852638)